ORGANIZATION

OTC Groups Call for Enhancing Self-Medication Tax Break, Submit Request

July 19, 2019

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Japanese consumer healthcare industry groups submitted their request to the health ministry on July 17 towards the government’s FY2020 tax reform, urging it to expand the scope of products eligible for the self-medication tax break, which is currently limited to…

To read the full story

Expand Self-Medication Tax Break and Make It Permanent: Industry Groups
July 20, 2020
Self-Medication Tax Break Not a Clear-Cut System, Needs More Awareness: LDP Lawmakers
October 11, 2019
OTC Group Unveils Reform Requests for Self-Medication Tax Break
June 25, 2019

ORGANIZATION

EFPIA Report Calls Japan a “Cautionary Tale” in 10-Country Biopharma Strategy Review
March 2, 2026
Pharma Takes Harsh View of FY2026 Pricing Reform: Policy Group Survey
February 24, 2026
JPMA to Push Govt to Scrap Market-Based Drug Price Revisions
February 20, 2026
Pharma Group Looks to Growth Strategy under Takaichi after Election Win
February 10, 2026
Pharma Groups Call for Faster Diagnosis and R&D for Intractable, Rare Diseases
February 9, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Elevidys Opens New Era for DMD Treatments Targeting the Underlying Cause

By Shinya Sato

Chugai Pharmaceutical’s Duchenne muscular dystrophy (DMD) gene therapy Elevidys has finally reached the Japanese market after months of safety reviews…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…